Identification, characterization, and bioconversion of a new intermediate in valanimycin biosynthesis

Area of Science:

• Microbiology
• Biochemistry
• Molecular Biology

Background:

• Valanimycin is a naturally occurring azoxy antibiotic produced by Streptomyces viridifaciens.
• Its biosynthetic pathway, particularly later stages, remains poorly understood.
• The vlmJ and vlmK genes were identified as potential key players in valanimycin biosynthesis.

Purpose of the Study:

• To elucidate the roles of vlmJ and vlmK in valanimycin biosynthesis.
• To isolate and characterize intermediates in the valanimycin pathway.
• To understand the enzymatic mechanisms of valanimycin formation.

Main Methods:

• Isolation and structure elucidation of valanimycin hydrate from vlmJ and vlmK mutants.
• Genetic analysis of Streptomyces viridifaciens strains.
• Enzymatic assays to determine the function of VlmJ and VlmK proteins.

Main Results:

• Valanimycin hydrate was successfully isolated from S. viridifaciens mutants lacking vlmJ and vlmK.
• The conversion of valanimycin hydrate to valanimycin requires both vlmJ and vlmK genes.
• VlmJ catalyzes ATP-dependent phosphorylation of valanimycin hydrate, followed by VlmK-catalyzed dehydration.

Conclusions:

• The vlmJ and vlmK genes are crucial for the final conversion of valanimycin hydrate to valanimycin.
• VlmJ acts as a kinase, and VlmK as a dehydratase in the valanimycin biosynthetic pathway.
• This study clarifies key enzymatic steps in the production of the antibiotic valanimycin.